1. Home
  2. SRDX vs IBEX Comparison

SRDX vs IBEX Comparison

Compare SRDX & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • IBEX
  • Stock Information
  • Founded
  • SRDX 1979
  • IBEX 2017
  • Country
  • SRDX United States
  • IBEX United States
  • Employees
  • SRDX N/A
  • IBEX N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • IBEX EDP Services
  • Sector
  • SRDX Health Care
  • IBEX Technology
  • Exchange
  • SRDX Nasdaq
  • IBEX Nasdaq
  • Market Cap
  • SRDX 416.3M
  • IBEX 386.9M
  • IPO Year
  • SRDX 1998
  • IBEX 2020
  • Fundamental
  • Price
  • SRDX $28.87
  • IBEX $37.50
  • Analyst Decision
  • SRDX Buy
  • IBEX Hold
  • Analyst Count
  • SRDX 3
  • IBEX 3
  • Target Price
  • SRDX $43.00
  • IBEX $31.00
  • AVG Volume (30 Days)
  • SRDX 138.2K
  • IBEX 266.5K
  • Earning Date
  • SRDX 11-05-2025
  • IBEX 11-06-2025
  • Dividend Yield
  • SRDX N/A
  • IBEX N/A
  • EPS Growth
  • SRDX N/A
  • IBEX 28.02
  • EPS
  • SRDX N/A
  • IBEX 2.36
  • Revenue
  • SRDX $120,801,000.00
  • IBEX $558,273,000.00
  • Revenue This Year
  • SRDX N/A
  • IBEX $10.15
  • Revenue Next Year
  • SRDX $3.38
  • IBEX $5.82
  • P/E Ratio
  • SRDX N/A
  • IBEX $15.97
  • Revenue Growth
  • SRDX N/A
  • IBEX 9.77
  • 52 Week Low
  • SRDX $26.00
  • IBEX $17.53
  • 52 Week High
  • SRDX $40.39
  • IBEX $42.99
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 25.36
  • IBEX 51.17
  • Support Level
  • SRDX $29.54
  • IBEX $37.26
  • Resistance Level
  • SRDX $30.19
  • IBEX $41.71
  • Average True Range (ATR)
  • SRDX 0.74
  • IBEX 1.33
  • MACD
  • SRDX -0.21
  • IBEX -0.73
  • Stochastic Oscillator
  • SRDX 6.26
  • IBEX 2.14

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

Share on Social Networks: